PTO- 1581 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Input Field |
Entered |
SERIAL NUMBER | 90387503 |
---|---|
LAW OFFICE ASSIGNED | LAW OFFICE 113 |
MARK SECTION | |
MARK | RAPIDVAX (see, http://uspto.report/TM/90387503/mark.png) |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | RAPIDVAX |
OWNER SECTION (current) | |
NAME | Heat Biologics, Inc. |
MAILING ADDRESS | 801 Capitola Drive, Bay 12 |
CITY | Durham |
STATE | North Carolina |
ZIP/POSTAL CODE | 27713 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
XXXX | |
OWNER SECTION (proposed) | |
NAME | Heat Biologics, Inc. |
MAILING ADDRESS | 801 Capitola Drive, Bay 12 |
CITY | Durham |
STATE | North Carolina |
ZIP/POSTAL CODE | 27713 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
XXXX | |
CORRESPONDENCE INFORMATION (current) | |
NAME | RACHELLE A. DUBOW, ESQ. |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | trademarks@morganlewis.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | rachelle.dubow@morganlewis.com; peter.byrne@morganlewis.com; jennifer.kagan@morganlewis.com |
CORRESPONDENCE INFORMATION (proposed) | |
NAME | Rachelle A. Dubow, Esq. |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | trademarks@morganlewis.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | rachelle.dubow@morganlewis.com; peter.byrne@morganlewis.com; jennifer.kagan@morganlewis.com |
DOCKET/REFERENCE NUMBER | 114358-0002 |
GOODS AND/OR SERVICES SECTION | |
INTERNATIONAL CLASS | 005 |
CURRENT IDENTIFICATION | Pharmaceutical preparations for the treatment or prevention of cancer, immune-related diseases, and infectious diseases |
GOODS OR SERVICES | KEEP ALL LISTED |
INTERNATIONAL CLASS | 042 |
CURRENT IDENTIFICATION | Research and development of pharmaceutical products |
GOODS OR SERVICES | KEEP ALL LISTED |
EXTENSION SECTION | |
EXTENSION NUMBER | 1 |
ALLOWANCE MAIL DATE | 06/15/2021 |
STATEMENT OF USE | NO |
PAYMENT SECTION | |
NUMBER OF CLASSES | 2 |
SUBTOTAL AMOUNT [EXTENSION FEE] | 250 |
TOTAL AMOUNT | 250 |
SIGNATURE SECTION | |
SIGNATURE | /Jeffrey Wolf/ |
SIGNATORY'S NAME | Jeffrey Wolf |
SIGNATORY'S POSITION | CEO |
DATE SIGNED | 12/14/2021 |
SIGNATORY'S PHONE NUMBER | 9192407133 |
SIGNATURE METHOD | Sent to third party for signature |
FILING INFORMATION | |
SUBMIT DATE | Tue Dec 14 16:54:42 ET 2021 |
TEAS STAMP | USPTO/ESU-XXX.XXX.XXX.XX- 20211214165442736556-9038 7503-781d28b68a72cbbb7dfb 5d417ba66163f9421e06fb7b3 94864dddc70762ba6f6f6-DA- 54404161-2021121313000948 1703 |
PTO- 1581 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |